BAT(TM) test platform does not require any instrumentation and is simple to operate, enabling microbiology testing outside of traditional laboratory settings.
I am very excited with the opportunity to serve on the MicroPhage
Board of Directors.
Building on original research licensed from the Colorado School of Mines, MicroPhage
has adapted Bacteriophage Amplification, a natural biologic process, for identifying bacterial infections.
aureus identification and antibiotic susceptibility testing, and it is designed to complement the demands of hospitals and laboratories of all sizes," said MicroPhage
CEO, Alene Campbell.
Campbell's experience and successful history with MicroPhage
makes the Board comfortable to appoint her to this position," said MicroPhage
Our initial product, as well as the family of tests we intend to offer based on our Bacteriophge Amplification platform, represents a new paradigm for the effective, cost-effective testing of hospital patients," said MicroPhage
CEO, Steve Lundy.
This insight will be important for MicroPhage
as we position our innovative and more cost-effective diagnostic solutions.
test platform requires no instrumentation and is composed of two small reaction tubes for incubating blood culture specimens.
Table 13: MRSA/MSSA Blood Culture Test - Primary Investigation Into the Performance of the MicroPhage
Director, Research and Development at MicroPhage
, test performance at the three sites exceeded all study goals for the prototype.
PHILADELPHIA -- In a presentation at the current General Meeting of the American Society for Microbiology (ASM) being held in Philadelphia, PA, a simple and inexpensive developmental diagnostic assay produced by MicroPhage
The announcement is made by John Collar, CBSA President & CEO, who says Jory assumes chairperson responsibilities from Jack Wheeler, entrepreneur and founder of MicroPhage